1
|
Stokes A, Karadakhy O, Lui C, Argyriou A, Almansoor Z, Adegboye O, Biswas S, Raj Krishna G, Agrawal D, Shah A, Kirkwood G, Morris G. Long-term lead and mortality following pacemaker and defibrillator implantation in adult congenital heart disease. Eur Heart J 2022. [DOI: 10.1093/eurheartj/ehac544.740] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Abstract
Background
Adult congenital heart disease (ACHD) survival has dramatically improved in recent decades. As such, clinicians now face the complex long-term interactions of congenital and chronic heart diseases. One area of continuing mortality in this group is arrhythmias, especially in those with cardiovascular implantable electronic devices (CIEDs). With these developments in survival, the long-term outcomes of the CIED systems and their effects on mortality are beginning to be elucidated.
Aims
This study aims to compare the effects of system location, surgical history, patient demographics and congenital disease complexity on lead survival, complication distributions and patient mortality in ACHD CIED patients.
Methods
A retrospective cohort of 250 ACHD CIED patients with follow up at a heart centre was collated from clinical correspondence letters and CEID records. Data was collected on demographics, mortality and lead survival and complications. Survival data was analysed with Kaplan-Meier (KM) curves and hazard ratio tests.
Results
Complex ADHD patient survival was less than the non-complex cohort (HR 0.38, 95% CI 0.22–0.67, p<0.01). Lead survival was longer in non-surgical patients (HR 1.42, 95% CI 1.13–1.78, p<0.01) and longer in female patients (HR 1.35, 95% CI 1.07–1.69, p<0.01) (Figure 1). No significant differences in mortality or lead survival were seen between epicardial and transvenous systems.
Conclusions
Complex ACHD is associated with worse patient mortality in CEID patients. Surgical history and male gender are associated with worsened lead survival.
Funding Acknowledgement
Type of funding sources: None.
Collapse
Affiliation(s)
- A Stokes
- Manchester Royal Infirmary , Manchester , United Kingdom
| | - O Karadakhy
- Manchester Royal Infirmary , Manchester , United Kingdom
| | - C Lui
- East Lancashire Hospitals NHS Trust , Blackburn , United Kingdom
| | - A Argyriou
- University of Manchester , Manchester , United Kingdom
| | - Z Almansoor
- University of Manchester , Manchester , United Kingdom
| | - O Adegboye
- University of Manchester , Manchester , United Kingdom
| | - S Biswas
- University of Manchester , Manchester , United Kingdom
| | - G Raj Krishna
- University of Manchester , Manchester , United Kingdom
| | - D Agrawal
- University of Manchester , Manchester , United Kingdom
| | - A Shah
- St. Boniface General Hospital, Department of Internal Medicine; Section of Cardiology , Winnipeg , Canada
| | - G Kirkwood
- Sheffield Teaching Hospitals NHS Trust , Sheffield , United Kingdom
| | - G Morris
- Manchester Royal Infirmary , Manchester , United Kingdom
| |
Collapse
|
2
|
Weemstra M, Roumet C, Cruz-Maldonado N, Anthelme F, Stokes A, Freschet GT. Environmental variation drives the decoupling of leaf and root traits within species along an elevation gradient. Ann Bot 2022; 130:419-430. [PMID: 35405006 PMCID: PMC9486920 DOI: 10.1093/aob/mcac052] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 02/10/2022] [Accepted: 04/06/2022] [Indexed: 06/14/2023]
Abstract
BACKGROUND AND AIMS Plant performance is enhanced by balancing above- and below-ground resource uptake through the intraspecific adjustment of leaf and root traits. It is assumed that these organ adjustments are at least partly coordinated, so that analogous leaf and root traits broadly covary. Understanding the extent of such intraspecific leaf-root trait covariation would strongly contribute to our understanding of how plants match above- and below-ground resource use strategies as their environment changes, but comprehensive studies are lacking. METHODS We measured analogous leaf and root traits from 11 species, as well as climate, soil and vegetation properties along a 1000-m elevation gradient in the French Alps. We determined how traits varied along the gradient, to what extent this variation was determined by the way different traits respond to environmental cues acting at different spatial scales (i.e. within and between elevations), and whether trait pairs covaried within species. KEY RESULTS Leaf and root trait patterns strongly diverged: across the 11 species along the gradient, intraspecific leaf trait patterns were largely consistent, whereas root trait patterns were highly idiosyncratic. We also observed that, when compared with leaves, intraspecific variation was greater in root traits, due to the strong effects of the local environment (i.e. at the same elevation), while landscape-level effects (i.e. at different elevations) were minor. Overall, intraspecific trait correlations between analogous leaf and root traits were nearly absent. CONCLUSIONS Our study suggests that environmental gradients at the landscape level, as well as local heterogeneity in soil properties, are the drivers of a strong decoupling between analogous leaf and root traits within species. This decoupling of plant resource acquisition strategies highlights how plants can exhibit diverse whole-plant acclimation strategies to modify above- and below-ground resource uptake, improving their resilience to environmental change.
Collapse
Affiliation(s)
| | - C Roumet
- CEFE, University of Montpellier, CNRS, EPHE, IRD, Montpellier, France
| | - N Cruz-Maldonado
- AMAP, INRAE, CIRAD, IRD, CNRS, University of Montpellier, Montpellier, France
| | - F Anthelme
- AMAP, INRAE, CIRAD, IRD, CNRS, University of Montpellier, Montpellier, France
| | - A Stokes
- AMAP, INRAE, CIRAD, IRD, CNRS, University of Montpellier, Montpellier, France
| | - G T Freschet
- Station d’Ecologie Théorique et Expérimentale, CNRS, 2 route du CNRS, 09200 Moulis, France
| |
Collapse
|
3
|
Carlesso LC, Jafarzadeh SR, Stokes A, Felson DT, Wang N, Frey-Law L, Lewis CE, Nevitt M, Neogi T. Depressive symptoms and multi-joint pain partially mediate the relationship between obesity and opioid use in people with knee osteoarthritis. Osteoarthritis Cartilage 2022; 30:1263-1269. [PMID: 35700904 PMCID: PMC9419857 DOI: 10.1016/j.joca.2022.06.002] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 02/14/2022] [Revised: 06/02/2022] [Accepted: 06/07/2022] [Indexed: 02/02/2023]
Abstract
OBJECTIVES To assess the relation of obesity to opioid use in people with or at risk of knee osteoarthritis (OA), and the extent to which this association is mediated by number of painful joints or depressive symptoms. METHODS We used data from the Multicenter Osteoarthritis Study, a longitudinal cohort of older adults with or at risk of knee OA. Opioid use was identified by prescription medications and self-report. Obesity was defined as BMI ≥ 30 kg/m2. Multi-joint pain was assessed using a standardized body homunculus, and depressive symptoms using the Center for Epidemiological Studies Depression scale. We quantified the direct and indirect effect of obesity on opioid use through the number of painful joints or depressive symptoms using causal mediation analysis by natural-effects models. RESULTS We studied 2,335 participants (mean age: 68; mean BMI 31 kg/m2; 60% women). Persons with obesity had ∼50% higher odds of opioid use than those without. Estimates of indirect (mediated) effect by the number of painful joints and depressive symptoms suggested an increased odds of opioid use by 34% (odds ratio [OR] = 1.34, 95% CI: 1.04, 1.70) and 35% (OR 1.35, 95% CI: 1.05, 1.71), respectively, in obese vs non-obese individuals. The total effect of obesity on opioid use was higher in women than in men. CONCLUSIONS Multi-joint pain and depressive symptoms partially explained greater opioid use among obese persons with knee OA, demonstrating that the negative impact of obesity on knee OA extends beyond its influence on knee pain and structural progression.
Collapse
Affiliation(s)
- L C Carlesso
- School of Rehabilitation Science, McMaster University, Hamilton, Ontario, Canada.
| | | | - A Stokes
- Boston University School of Public Health, Boston, MA, USA.
| | - D T Felson
- Boston University School of Medicine, Boston, MA, USA.
| | - N Wang
- Biostatistics and Epidemiology Data Analytics Center (BEDAC), Boston University School of Public Health, Boston, MA, USA.
| | - L Frey-Law
- Department of Physical Therapy and Rehabilitation Science, University of Iowa, Iowa City, Iowa, USA.
| | - C E Lewis
- Department of Epidemiology, University of Alabama at Birmingham, School of Public Health, Birmingham, AL, USA.
| | - M Nevitt
- University of California, San Francisco, CA, USA.
| | - T Neogi
- Boston University School of Medicine, Boston, MA, USA.
| |
Collapse
|
4
|
Jansen C, Shimoda L, Kawakami J, Ang L, Bacani A, Baker J, Badowski C, Speck M, Stokes A, Small-Howard A, Turner H. Myrcene and terpene regulation of TRPV1. Channels (Austin) 2019; 13:344-366. [PMID: 31446830 PMCID: PMC6768052 DOI: 10.1080/19336950.2019.1654347] [Citation(s) in RCA: 41] [Impact Index Per Article: 8.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/10/2019] [Revised: 08/05/2019] [Accepted: 08/06/2019] [Indexed: 01/30/2023] Open
Abstract
Nociceptive Transient Receptor Potential channels such as TRPV1 are targets for treating pain. Both antagonism and agonism of TRP channels can promote analgesia, through inactivation and chronic desensitization. Since plant-derived mixtures of cannabinoids and the Cannabis component myrcene have been suggested as pain therapeutics, we screened terpenes found in Cannabis for activity at TRPV1. We used inducible expression of TRPV1 to examine TRPV1-dependency of terpene-induced calcium flux responses. Terpenes contribute differentially to calcium fluxes via TRPV1 induced by Cannabis-mimetic cannabinoid/terpenoid mixtures. Myrcene dominates the TRPV1-mediated calcium responses seen with terpenoid mixtures. Myrcene-induced calcium influx is inhibited by the TRPV1 inhibitor capsazepine and Myrcene elicits TRPV1 currents in the whole-cell patch-clamp configuration. TRPV1 currents are highly sensitive to internal calcium. When Myrcene currents are evoked, they are distinct from capsaicin responses on the basis of Imax and their lack of shift to a pore-dilated state. Myrcene pre-application and residency at TRPV1 appears to negatively impact subsequent responses to TRPV1 ligands such as Cannabidiol, indicating allosteric modulation and possible competition by Myrcene. Molecular docking studies suggest a non-covalent interaction site for Myrcene in TRPV1 and identifies key residues that form partially overlapping Myrcene and Cannabidiol binding sites. We identify several non-Cannabis plant-derived sources of Myrcene and other compounds targeting nociceptive TRPs using a data mining approach focused on analgesics suggested by non-Western Traditional Medical Systems. These data establish TRPV1 as a target of Myrcene and suggest the therapeutic potential of analgesic formulations containing Myrcene.
Collapse
Affiliation(s)
- C. Jansen
- Laboratory of Immunology and Signal Transduction, Chaminade University, Honolulu, HI, USA
| | - L.M.N Shimoda
- Laboratory of Immunology and Signal Transduction, Chaminade University, Honolulu, HI, USA
| | - J.K. Kawakami
- Department of Chemistry, Chaminade University, Honolulu, HI, USA
| | - L. Ang
- Undergraduate Program in Biology, Chaminade University, Honolulu, HI, USA
| | - A.J. Bacani
- Undergraduate Program in Biology, Chaminade University, Honolulu, HI, USA
| | - J.D. Baker
- Department of Biology, Chaminade University, Honolulu, HI, USA
| | - C. Badowski
- Laboratory of Experimental Medicine, John A. Burns School of Medicine, Honolulu, HI, USA
| | - M. Speck
- Laboratory of Immunology and Signal Transduction, Chaminade University, Honolulu, HI, USA
| | - A.J. Stokes
- Laboratory of Experimental Medicine, John A. Burns School of Medicine, Honolulu, HI, USA
| | | | - H Turner
- Laboratory of Immunology and Signal Transduction, Chaminade University, Honolulu, HI, USA
| |
Collapse
|
5
|
Abstract
Background Obesity is a risk factor for numerous cancer types, and may influence cancer treatment outcomes. Underrepresentation of obese patients in obesity-related cancer randomized controlled trials (RCTs) may affect generalizability of results. We aimed to assess the reporting of information about eligibility and enrollment of obese participants in obesity-related cancer RCTs. Methods We conducted a systematic review of RCTs of 10 obesity-related cancer types (esophagus, colon/rectum, liver, gallbladder, pancreas, postmenopausal breast, endometrium, ovary, kidney, and thyroid cancer). We selected RCTs published between 2013 and 2016 in five major journals. For each trial, we examined the article, the protocol, and the registration record. We assessed if eligibility criteria limiting the enrollment of obese participants were reported, the proportion of obese participants that were enrolled, and if a subgroup analysis according to obesity status was reported. We systematically contacted corresponding authors and asked for information about eligibility of obese participants and the proportion of obese participants. Results We included 76 RCTs. Colon/rectum (n = 20), postmenopausal breast (n = 11), and kidney (n = 11) cancers were the most frequent types. Based on publicly available sources, information on the eligibility of obese participants was available in 5 (7%) trials. The proportion of obese participants could be estimated in 9 (12%) trials only. We found a subgroup analysis in only one RCT. When considering unpublished information, the eligibility of obese participants was explicitly stated in 31 (41%) trials but it was unclear if the remaining 59% trials considered obese participants as eligible and what proportion of obese participants was included. Across 22 trials, the median proportion of obese participants included was 18% (Q1-Q3 11-23). Conclusion Information on the eligibility and enrollment of obese participants in cancer RCTs is dramatically underreported. More transparency is needed to understand the applicability of obesity-related cancer RCT results to obese patients with cancer.
Collapse
Affiliation(s)
- E Pestine
- Department of Biostatistics, Boston University School of Public Health, Boston, USA
| | - A Stokes
- Department of Global Health, Boston University School of Public Health, Boston, USA
| | - L Trinquart
- Department of Biostatistics, Boston University School of Public Health, Boston, USA.
| |
Collapse
|
6
|
Schmainda KM, Prah MA, Hu LS, Quarles CC, Semmineh N, Rand SD, Connelly JM, Anderies B, Zhou Y, Liu Y, Logan B, Stokes A, Baird G, Boxerman JL. Moving Toward a Consensus DSC-MRI Protocol: Validation of a Low-Flip Angle Single-Dose Option as a Reference Standard for Brain Tumors. AJNR Am J Neuroradiol 2019; 40:626-633. [PMID: 30923088 DOI: 10.3174/ajnr.a6015] [Citation(s) in RCA: 14] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/13/2018] [Accepted: 01/18/2019] [Indexed: 12/21/2022]
Abstract
BACKGROUND AND PURPOSE DSC-MR imaging using preload, intermediate (60°) flip angle and postprocessing leakage correction has gained traction as a standard methodology. Simulations suggest that DSC-MR imaging with flip angle = 30° and no preload yields relative CBV practically equivalent to the reference standard. This study tested this hypothesis in vivo. MATERIALS AND METHODS Eighty-four patients with brain lesions were enrolled in this 3-institution study. Forty-three patients satisfied the inclusion criteria. DSC-MR imaging (3T, single-dose gadobutrol, gradient recalled-echo-EPI, TE = 20-35 ms, TR = 1.2-1.63 seconds) was performed twice for each patient, with flip angle = 30°-35° and no preload (P-), which provided preload (P+) for the subsequent intermediate flip angle = 60°. Normalized relative CBV and standardized relative CBV maps were generated, including postprocessing with contrast agent leakage correction (C+) and without (C-) contrast agent leakage correction. Contrast-enhancing lesion volume, mean relative CBV, and contrast-to-noise ratio obtained with 30°/P-/C-, 30°/P-/C+, and 60°/P+/C- were compared with 60°/P+/C+ using the Lin concordance correlation coefficient and Bland-Altman analysis. Equivalence between the 30°/P-/C+ and 60°/P+/C+ protocols and the temporal SNR for the 30°/P- and 60°/P+ DSC-MR imaging data was also determined. RESULTS Compared with 60°/P+/C+, 30°/P-/C+ had closest mean standardized relative CBV (P = .61), highest Lin concordance correlation coefficient (0.96), and lowest Bland-Altman bias (μ = 1.89), compared with 30°/P-/C- (P = .02, Lin concordance correlation coefficient = 0.59, μ = 14.6) and 60°/P+/C- (P = .03, Lin concordance correlation coefficient = 0.88, μ = -10.1) with no statistical difference in contrast-to-noise ratios across protocols. The normalized relative CBV and standardized relative CBV were statistically equivalent at the 10% level using either the 30°/P-/C+ or 60°/P+/C+ protocols. Temporal SNR was not significantly different for 30°/P- and 60°/P+ (P = .06). CONCLUSIONS Tumor relative CBV derived from low-flip angle, no-preload DSC-MR imaging with leakage correction is an attractive single-dose alternative to the higher dose reference standard.
Collapse
Affiliation(s)
- K M Schmainda
- From the Departments of Biophysics (K.M.S., M.A.P.) .,Radiology (K.M.S., S.D.R.)
| | - M A Prah
- From the Departments of Biophysics (K.M.S., M.A.P.)
| | - L S Hu
- Departments of Radiology (L.S.H., Y.Z.)
| | - C C Quarles
- Division of Imaging Research (C.C.Q., N.S., A.S.), Barrow Neurological Institute, Phoenix, Arizona
| | - N Semmineh
- Division of Imaging Research (C.C.Q., N.S., A.S.), Barrow Neurological Institute, Phoenix, Arizona
| | | | | | - B Anderies
- Neurosurgery (B.A.), Mayo Clinic, Scottsdale, Arizona
| | - Y Zhou
- Departments of Radiology (L.S.H., Y.Z.)
| | - Y Liu
- Division of Biostatistics, Institute for Health and Society (Y.L., B.L.), Medical College of Wisconsin, Milwaukee, Wisconsin
| | - B Logan
- Division of Biostatistics, Institute for Health and Society (Y.L., B.L.), Medical College of Wisconsin, Milwaukee, Wisconsin
| | - A Stokes
- Division of Imaging Research (C.C.Q., N.S., A.S.), Barrow Neurological Institute, Phoenix, Arizona
| | - G Baird
- Department of Diagnostic Imaging (J.L.B., G.B.), Rhode Island Hospital and Warren Alpert Medical School of Brown University, Providence, Rhode Island
| | - J L Boxerman
- Department of Diagnostic Imaging (J.L.B., G.B.), Rhode Island Hospital and Warren Alpert Medical School of Brown University, Providence, Rhode Island
| |
Collapse
|
7
|
Rey F, Bifulco C, Bischetti GB, Bourrier F, De Cesare G, Florineth F, Graf F, Marden M, Mickovski SB, Phillips C, Peklo K, Poesen J, Polster D, Preti F, Rauch HP, Raymond P, Sangalli P, Tardio G, Stokes A. Soil and water bioengineering: Practice and research needs for reconciling natural hazard control and ecological restoration. Sci Total Environ 2019; 648:1210-1218. [PMID: 30340266 DOI: 10.1016/j.scitotenv.2018.08.217] [Citation(s) in RCA: 15] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 06/22/2018] [Revised: 08/16/2018] [Accepted: 08/17/2018] [Indexed: 06/08/2023]
Abstract
Soil and water bioengineering is a technology that encourages scientists and practitioners to combine their knowledge and skills in the management of ecosystems with a common goal to maximize benefits to both man and the natural environment. It involves techniques that use plants as living building materials, for: (i) natural hazard control (e.g., soil erosion, torrential floods and landslides) and (ii) ecological restoration or nature-based re-introduction of species on degraded lands, river embankments, and disturbed environments. For a bioengineering project to be successful, engineers are required to highlight all the potential benefits and ecosystem services by documenting the technical, ecological, economic and social values. The novel approaches used by bioengineers raise questions for researchers and necessitate innovation from practitioners to design bioengineering concepts and techniques. Our objective in this paper, therefore, is to highlight the practice and research needs in soil and water bioengineering for reconciling natural hazard control and ecological restoration. Firstly, we review the definition and development of bioengineering technology, while stressing issues concerning the design, implementation, and monitoring of bioengineering actions. Secondly, we highlight the need to reconcile natural hazard control and ecological restoration by posing novel practice and research questions.
Collapse
Affiliation(s)
- F Rey
- Univ. Grenoble Alpes, Irstea, UR LESSEM, 2 rue de la Papeterie, BP 76, 38402 Saint-Martin-d'Hères, France.
| | - C Bifulco
- Universidade de Lisboa, Instituto Superior de Agronomia, Centro de Ecologia Aplicada Prof. Baeta Neves, Lisboa, Portugal
| | - G B Bischetti
- Department of Agricultural and Environmental Science, Università degli Studi di Milano, Milan, Italy.
| | - F Bourrier
- Univ. Grenoble Alpes, Irstea, UR LESSEM, 2 rue de la Papeterie, BP 76, 38402 Saint-Martin-d'Hères, France.
| | - G De Cesare
- Laboratory of Hydraulic Constructions LCH, École Polytechnique Fédérale de Lausanne EPFL, Station 18, CH-1015 Lausanne, Switzerland.
| | - F Florineth
- Institute of Soil Bioengineering and Landscape Construction, Department of Civil Engineering and Natural Hazards, University of Natural Resources and Life Sciences, Vienna, Austria.
| | - F Graf
- WSL Institute for Snow and Avalanche Research SLF, Flüelastrasse 11, CH-7260 Davos Dorf, Switzerland.
| | - M Marden
- Landcare Research, PO Box 445, Gisborne 4040, New Zealand.
| | - S B Mickovski
- School of Engineering and Built Environment, Glasgow Caledonian University, 70 Cowcaddens Rd, Glasgow G4 0BA, Scotland, UK.
| | - C Phillips
- Landcare Research, PO Box 69040, Lincoln 7640, New Zealand.
| | - K Peklo
- I.C.E. Klaus PEKLO, Soil and Fluvial Bioengineering Consultancy SARL, Lasmarios, 82160, Parisot, France
| | - J Poesen
- Department of Earth and Environmental Sciences, KU Leuven, Celestijnenlaan 200E, B-3001 Heverlee, Belgium.
| | - D Polster
- Polster Environmental Services, 6015 Mary Street, Duncan, BC V9L 2G5, Canada.
| | - F Preti
- University Firenze - GESAAF, Engineering for Agro-Forestry and Biosystems Division, WaVe Research Unit, via san Bonaventura 13, 50145 Firenze, Italy.
| | - H P Rauch
- Institute of Soil Bioengineering and Landscape Construction, Department of Civil Engineering and Natural Hazards, University of Natural Resources and Life Sciences, Vienna, Austria.
| | - P Raymond
- Terra Erosion Control Ltd., 308 Hart Street, Nelson, British Columbia V1L5N5, Canada.
| | - P Sangalli
- Sangalli Coronel y AsociadosSL, Bioingeniería y Paisaje Montesol, 24-20016 San Sebastian, Spain.
| | - G Tardio
- Technical University of Madrid, Avenida Niceto Alcalá Zamora 6 4D, Getafe, Madrid 28905, Spain
| | - A Stokes
- INRA, AMAP, CNRS, IRD, University Montpellier, CIRAD, Montpellier, France.
| |
Collapse
|
8
|
Wang Y, Kim JH, Mao Z, Ramel M, Pailler F, Perez J, Rey H, Tron S, Jourdan C, Stokes A. Tree root dynamics in montane and sub-alpine mixed forest patches. Ann Bot 2018; 122:861-872. [PMID: 29506133 PMCID: PMC6215049 DOI: 10.1093/aob/mcy021] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 11/21/2017] [Accepted: 02/02/2018] [Indexed: 06/08/2023]
Abstract
BACKGROUND AND AIMS The structure of heterogeneous forests has consequences for their biophysical environment. Variations in the local climate significantly affect tree physiological processes. We hypothesize that forest structure also alters tree root elongation and longevity through temporal and spatial variations in soil temperature and water potential. METHODS We installed rhizotrons in paired vegetation communities of closed forest (tree islands) and open patches (canopy gaps), along a soil temperature gradient (elevations of 1400, 1700 and 2000 m) in a heterogeneous mixed forest. We measured the number of growing tree roots, elongation and mortality every month over 4 years. KEY RESULTS The results showed that the mean daily root elongation rate (RER) was not correlated with soil water potential but was significantly and positively correlated with soil temperature between 0 and 8 °C only. The RER peaked in spring, and a smaller peak was usually observed in the autumn. Root longevity was dependent on altitude and the season in which roots were initiated, and root diameter was a significant factor explaining much of the variability observed. The finest roots usually grew faster and had a higher risk of mortality in gaps than in closed forest. At 2000 m, the finest roots had a higher risk of mortality compared with the lower altitudes. CONCLUSIONS The RER was largely driven by soil temperature and was lower in cold soils. At the treeline, ephemeral fine roots were more numerous, probably in order to compensate for the shorter growing season. Differences in soil climate and root dynamics between gaps and closed forest were marked at 1400 and 1700 m, but not at 2000 m, where canopy cover was more sparse. Therefore, heterogeneous forest structure and situation play a significant role in determining root demography in temperate, montane forests, mostly through impacts on soil temperature.
Collapse
Affiliation(s)
- Y Wang
- University Montpellier, INRA, CNRS, IRD, CIRAD, AMAP, Montpellier, France
| | - J H Kim
- University Montpellier, INRA, CNRS, IRD, CIRAD, AMAP, Montpellier, France
- Max Planck Institute of Biogeochemistry, Jena, Germany
| | - Z Mao
- University Montpellier, INRA, CNRS, IRD, CIRAD, AMAP, Montpellier, France
| | - M Ramel
- University Montpellier, INRA, CNRS, IRD, CIRAD, AMAP, Montpellier, France
| | - F Pailler
- University Montpellier, INRA, CNRS, IRD, CIRAD, AMAP, Montpellier, France
| | - J Perez
- University Montpellier, INRA, CNRS, IRD, CIRAD, AMAP, Montpellier, France
| | - H Rey
- University Montpellier, INRA, CNRS, IRD, CIRAD, AMAP, Montpellier, France
| | - S Tron
- ÖGUT, Austrian Society for Environment and Technology, Vienna, Austria
| | - C Jourdan
- CIRAD, UMR Eco&Sols – Ecologie Fonctionnelle & Biogéochimie des Sols & Agroécosystèmes (Montpellier SupAgro-CIRAD-INRA-IRD), Montpellier, France
| | - A Stokes
- University Montpellier, INRA, CNRS, IRD, CIRAD, AMAP, Montpellier, France
| |
Collapse
|
9
|
Sullivan R, Randhawa V, Stokes A, Wu D, Lalonde T, Luyt L, Wisenberg G, Dhanvantari S. THE GROWTH HORMONE SECRETAGOGUE RECEPTOR, GHRELIN AND BIOCHEMICAL SIGNALING MOLECULES IN HUMAN HEART DISEASE. Can J Cardiol 2018. [DOI: 10.1016/j.cjca.2018.07.302] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022] Open
|
10
|
Dhumale SR, Barraclough TW, Stokes A, Lam W. Producing 3D printed hand models for anatomy education using cadaveric dissection: a feasibility study. ACTA ACUST UNITED AC 2018. [DOI: 10.1308/rcsbull.2018.217] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
Abstract
What are the potential benefits and problems?
Collapse
Affiliation(s)
- SR Dhumale
- Edinburgh Medical School: Biomedical Sciences, University of Edinburgh, Edinburgh, UK
| | - TW Barraclough
- Stokes Research Group, Institute for Integrated Micro and Nano Systems, School of Engineering, University of Edinburgh, Edinburgh, UK
| | - A Stokes
- Stokes Research Group, Institute for Integrated Micro and Nano Systems, School of Engineering, University of Edinburgh, Edinburgh, UK
| | - W Lam
- Royal Hospital for Sick Children, Edinburgh, and St John’s Hospital, Livingstone, Edinburgh; Centre for Human Anatomy, Edinburgh Medical School: Biomedical Sciences, University of Edinburgh, Edinburgh, UK
| |
Collapse
|
11
|
Sullivan R, Randhawa V, Stokes A, Liu S, Wu D, Charron C, Lalonde T, Luyt L, Kiaii B, Wisenberg G, Dhanvantari S. EXPRESSION OF THE GROWTH HORMONE SECRETAGOGUE RECEPTOR AND GHRELIN IN HUMAN HEART FAILURE. Can J Cardiol 2017. [DOI: 10.1016/j.cjca.2017.07.403] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022] Open
|
12
|
Affiliation(s)
- H R Banack
- Department of Epidemiology and Environmental Health, School of Public Health and Health Professions, University at Buffalo, The State University of New York, Buffalo, NY, USA
| | - A Stokes
- Department of Global Health and Center for Global Health and Development, Boston University School of Public Health, Boston, MA, USA
| |
Collapse
|
13
|
|
14
|
Garg A, Garg A, Tai K, Barontini S, Stokes A. A Computational Intelligence-Based Genetic Programming Approach for the Simulation of Soil Water Retention Curves. Transp Porous Media 2014. [DOI: 10.1007/s11242-014-0313-8] [Citation(s) in RCA: 34] [Impact Index Per Article: 3.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
15
|
Stokes A, Stokes H. Psycological and behavioral treatment of primary and secondary insomnia in patients from San Juan de Dios Hospital, Sleep Department of Guatemala. Sleep Med 2013. [DOI: 10.1016/j.sleep.2013.11.675] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
16
|
Baren JP, Stewart GD, Stokes A, Gray K, Pennington CJ, O'Neill R, Deans DAC, Paterson-Brown S, Riddick ACP, Edwards DR, Fearon KCH, Ross JA, Skipworth RJE. mRNA profiling of the cancer degradome in oesophago-gastric adenocarcinoma. Br J Cancer 2012; 107:143-9. [PMID: 22677901 PMCID: PMC3389427 DOI: 10.1038/bjc.2012.239] [Citation(s) in RCA: 15] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/10/2023] Open
Abstract
Background: Degradation of the extracellular matrix is fundamental to tumour development, invasion and metastasis. Several protease families have been implicated in the development of a broad range of tumour types, including oesophago–gastric (OG) adenocarcinoma. The aim of this study was to analyse the expression levels of all core members of the cancer degradome in OG adenocarcinoma and to investigate the relationship between expression levels and tumour/patient variables associated with poor prognosis. Methods: Comprehensive expression profiling of the protease families (matrix metalloproteinases (MMPs), members of the ADAM metalloproteinase-disintegrin family (ADAMs)), their inhibitors (tissue inhibitors of metalloproteinase), and molecules involved in the c-Met signalling pathway, was performed using quantitative real-time reverse transcription polymerase chain reaction in a cohort of matched malignant and benign peri-tumoural OG tissue (n=25 patients). Data were analysed with respect to clinico-pathological variables (tumour stage and grade, age, sex and pre-operative plasma C-reactive protein level). Results: Gene expression of MMP1, 3, 7, 9, 10, 11, 12, 16 and 24 was upregulated by factors >4-fold in OG adenocarcinoma samples compared with matched benign tissue (P<0.01). Expression of ADAM8 and ADAM15 correlated significantly with tumour stage (P=0.048 and P=0.044), and ADAM12 expression correlated with tumour grade (P=0.011). Conclusion: This study represents the first comprehensive quantitative analysis of the expression of proteases and their inhibitors in human OG adenocarcinoma. These findings implicate elevated ADAM8, 12 and 15 mRNA expression as potential prognostic molecular markers.
Collapse
Affiliation(s)
- J P Baren
- Tissue Injury and Repair Group, Clinical and Surgical Sciences, University of Edinburgh-MRC Centre for Regenerative Medicine, Royal Infirmary of Edinburgh, 51 Little France Crescent, Edinburgh, UK
| | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
17
|
Thomas S, Stokes A, Angulatta V, Ketchell I, Duckers J. 206 Stress urinary incontinence in adult CF patients: prevalence and physiotherapy management in Wales. J Cyst Fibros 2012. [DOI: 10.1016/s1569-1993(12)60376-2] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
|
18
|
Stokes A, Angulatta V, Mills R, Duckers J, Ketchell I. 175 Sinonasal disease in adult CF patients: prevalence and management in Wales. J Cyst Fibros 2012. [DOI: 10.1016/s1569-1993(12)60345-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
|
19
|
Stokes A, Ryle JA. A NOTE ON WEIL'S DISEASE (SPIROCHAETOSIS ICTERO-HAEMORRHAGICA) AS IT HAS OCCURRED IN THE ARMY IN FLANDERS. Br Med J 2011; 2:413-7. [PMID: 20768300 DOI: 10.1136/bmj.2.2908.413] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
|
20
|
Stokes A, Stokes H. Usefulness of polysomnography and videomonitorization in patients with learning disabilities. Clin Neurophysiol 2008. [DOI: 10.1016/s1388-2457(08)60662-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
21
|
Abstract
Mast cells are tissue-resident immune effector cells. They respond to diverse stimuli by releasing potent biological mediators into the surrounding tissue, and initiating inflammatory responses that promote wound healing and infection clearance. In addition to stimulation via immunological routes, mast cells also respond to polybasic secretagogues and physical stimuli. Each mechanism for mast cell activation relies on the influx of calcium through specific ion channels in the plasma membrane. Recent reports suggest that several calcium-permeant cation channels of the TRPV family are expressed in mast cells. TRPV channels are a family of sensors that receive and react to chemical messengers and physical environmental cues, including thermal, osmotic, and mechanical stimuli. The central premise of this review is that TRPVs transduce physiological and pathophysiological cues that are functionally coupled to calcium signaling and mediator release in mast cells. Inappropriate mast cell activation is at the core of numerous inflammatory pathologies, rendering the mast cell TRPV channels potentially important therapeutic targets.
Collapse
Affiliation(s)
- H Turner
- Center for Biomedical Research at Queen's Medical Center, University Tower 811, 1356 Lusitana Street, Honolulu, HI 96813, USA.
| | | | | |
Collapse
|
22
|
Affiliation(s)
- A Stokes
- THE CATHOLIC UNIVERSITY OF AMERICA
| |
Collapse
|
23
|
Pitchers M, Stokes A, Lonsdale R, Premachandra DJ, Edwards DR. Research tissue banking in otolaryngology: organization, methods and uses, with reference to practical, ethical and legal issues. J Laryngol Otol 2006; 120:433-8. [PMID: 16772051 DOI: 10.1017/s0022215106000429] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Accepted: 10/17/2005] [Indexed: 11/06/2022]
Abstract
The field of molecular biology is an important part of research into neoplastic conditions. Much of this research requires access to human tissue samples, which may need to be collected and stored in a specific way, according to the type of study for which they are intended. Anonymous clinical information about the samples enables researchers to apply results to different patient groups. Access to stored tissues is particularly important in head and neck disease research as many neoplastic conditions affecting this area have a relatively low incidence. Consequently, it may take a long time to build up enough individual cases to make a study worthwhile.We describe here the current legal, ethical and practical issues of research tissue banking, with regard to head and neck disease.
Collapse
Affiliation(s)
- M Pitchers
- School of Biological Sciences, University of East Anglia, Norwich, UK.
| | | | | | | | | |
Collapse
|
24
|
Reynolds TM, Stokes A, Russell L. Assessment of a prognostic biochemical indicator of nutrition and inflammation for identification of pressure ulcer risk. J Clin Pathol 2006; 59:308-10. [PMID: 16505284 PMCID: PMC1860338 DOI: 10.1136/jcp.2005.029405] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 06/08/2005] [Indexed: 11/04/2022]
Abstract
BACKGROUND Pressure ulcers represent a major cost to the healthcare systems of the world but preventative measures are expensive and could be better targeted. Current risk screening mechanisms are often subjective and could be improved. AIMS To evaluate whether a biochemical assessment tool (Prognostic Inflammatory and Nutritional Index; PINI) based on measurement of albumin, alpha1-acid glycoprotein, C-reactive protein, and prealbumin is of value in estimating the prognosis of patients with pressure ulcers of European Pressure Ulcer Advisory Panel grade 1 and above. METHODS Serum samples were collected from patients participating in a clinical trial of a pressure ulcer preventing mattress. These were analysed for the markers listed above and the PINI calculated. PINI was then evaluated against patient outcome. RESULTS A statistically significant difference between PINI values in patients whose pressure ulcers improved and those whose ulcers worsened was found in parametric testing, but significance was not achieved in non-parametric testing. A receiver operating characteristic plot showed the PINI was superior to chance in estimating prognosis. CONCLUSIONS The PINI appears to offer a potential route to improving pressure ulcer risk estimation and thus allocation of scarce equipment to improve prevention.
Collapse
Affiliation(s)
- T M Reynolds
- Clinical Chemistry Department, Queen's Hospital, Burton-on-Trent, Staffordshire, UK.
| | | | | |
Collapse
|
25
|
Dupuy L, Fourcaud T, Stokes A, Danjon F. A density-based approach for the modelling of root architecture: application to Maritime pine (Pinus pinaster Ait.) root systems. J Theor Biol 2006; 236:323-34. [PMID: 15961115 DOI: 10.1016/j.jtbi.2005.03.013] [Citation(s) in RCA: 36] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/11/2004] [Revised: 03/09/2005] [Accepted: 03/09/2005] [Indexed: 11/23/2022]
Abstract
Root morphology influences strongly plant/soil interactions. However, the complexity of root architecture is a major barrier when analysing many phenomena, e.g. anchorage, water or nutrient uptake. Therefore, we have developed a new approach for the representation and modelling of root architecture based on branching density. A general root branching density in a space of finite dimension was used and enabled us to consider various morphological properties. A root system model was then constructed which minimizes the difference between measured and simulated root systems, expressed with functions which map root density in the soil. The model was tested in 2D using data from Maritime pine Pinus pinaster Ait. structural roots as input. We showed that simulated and real root systems had similar root distributions in terms of radial distance, depth, branching angle and branching order. These results indicate that general density functions are not only a powerful basis for constructing models of architecture, but can also be used to represent such structures when considering root/soil interaction. These models are particularly useful in that they provide a local morphological characterization which is aggregated in a given unit of soil volume.
Collapse
Affiliation(s)
- L Dupuy
- Laboratoire de Rhéologie du Bois de Bordeaux, Mixed unit CNRS, INRA, Université Bordeaux I, Domaine de l'Hermitage 69 route d'Arcachon 33612 Cestas Cedex, France.
| | | | | | | |
Collapse
|
26
|
Affiliation(s)
- C Plomion
- Institut National de la Recherche Agronomique, Equipe de Génétique et Amélioration des Arbres Forestiers, BP45, 33610 Pierroton, France.
| | | | | |
Collapse
|
27
|
Affiliation(s)
- C Plomion
- Institut National de la Recherche Agronomique, Equipe de Génétique et Amélioration des Arbres Forestiers, BP45, 33610 Pierroton, France.
| | | | | |
Collapse
|
28
|
Schulman SL, Stokes A, Salzman PM. The efficacy and safety of oral desmopressin in children with primary nocturnal enuresis. J Urol 2001; 166:2427-31. [PMID: 11696804] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/22/2023]
Abstract
PURPOSE We confirmed findings that oral desmopressin safely decreases the number of wet nights in children with enuresis and identified doses at which acceptable responses can be obtained. MATERIALS AND METHODS We evaluated the safety and efficacy of oral desmopressin in a double-blind, placebo controlled, parallel group, randomized, multicenter trial of 193 children 6 to 16 years old with documented primary nocturnal enuresis. The study was conducted in 2 phases: 1) a 2-week dose ranging phase in which children received desmopressin (0.2, 0.4 or 0.6 mg.) or placebo at bedtime and 2) an 8-week dose titration phase that followed a 2-week placebo washout. Patients received 0.2 mg. desmopressin or placebo for the first 2 weeks and then the dose was increased in 0.2 mg. increments at 2-week intervals until the patient was completely dry or was receiving 0.6 mg. Patients were instructed to limit fluid intake. Mean decrease from baseline in the number of wet nights, percentage of responding patients and safety were assessed at 2-week intervals. RESULTS There was a statistically significant linear response to oral desmopressin at doses from 0.2 to 0.6 mg. during the dose ranging phase (p < or =0.05). The decrease in wet nights after 2 weeks of treatment with desmopressin was 27%, 30% and 40% at 0.2, 0.4 and 0.6 mg. doses, respectively, compared to 10% with placebo. All doses were statistically significantly different from placebo (p < or =0.05). During the dose titration phase all placebo treated and 87% of desmopressin treated patients were receiving the maximum dose of 3 tablets nightly because they had not been completely dry in the previous 2 weeks. Nevertheless, 44% of desmopressin treated patients had achieved at least a 50% reduction from baseline in the number of wet nights per 2 weeks at the lower doses of 0.2 and 0.4 mg. Most adverse events (rhinitis, pharyngitis, headache and increased cough) were mild to moderate in severity, unrelated to treatment and resolved before the study was completed. CONCLUSIONS Oral desmopressin administered at bedtime to children with primary nocturnal enuresis was significantly better than placebo for decreasing episodes of bed-wetting (p <0.05). A linear dose-response relationship was observed (p <0.05). An acceptable response to treatment (50% or greater reduction from baseline in wet nights per 2 weeks) was seen at all doses of desmopressin. Oral desmopressin, up to 0.6 mg. for 8 weeks, was well tolerated.
Collapse
Affiliation(s)
- S L Schulman
- Department of Pediatrics, Children's Hospital of Philadelphia, University of Pennsylvania School of Medicine, Philadelphia, USA
| | | | | |
Collapse
|
29
|
Affiliation(s)
- C Plomion
- Institut National de la Recherche Agronomique, Equipe de Génétique et Amélioration des Arbres Forestiers, BP45, 33610 Pierroton, France.
| | | | | |
Collapse
|
30
|
|
31
|
Alber DG, Killington RA, Stokes A. Solid matrix-antibody-antigen complexes incorporating equine herpesvirus 1 glycoproteins C and D elicit anti-viral immune responses in BALB/c (H-2K(d)) and C3H (H-2K(k)) mice. Vaccine 2000; 19:895-901. [PMID: 11115713 DOI: 10.1016/s0264-410x(00)00222-x] [Citation(s) in RCA: 12] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
Abstract
Glycoproteins C and D (gC and gD) derived from equine herpesvirus 1 (EHV-1)-infected cells were incorporated into individual solid matrix-antibody-antigen (SMAA) complexes and administered to BALB/c (H-2K(d)) and C3H (H-2K(k)) mice. Antibodies against each of the glycoproteins were produced that neutralised virus infectivity and mediated the lysis of EHV-1-infected target cells in the presence of complement. Immunoglobulin (Ig)G2b was the predominant antibody isotype produced in BALB/c mice against gC, while equal amounts of IgG2a/2b were found in the serum of C3H mice (indicative of a T-helper(1) response). Glycoprotein D immunisation elicited predominantly an IgG1 response in BALB/c mice (indicative of a T-helper(2) response) and an IgG2a/2b response in C3H mice. EHV-1-specific local and systemic T-cell proliferative responses were detected in vitro following administration of SMAA complexes. Suppression of the local T-cell response was seen following virus challenge of mice immunised with SMAA gC. SMAA gD provided some protection against intranasal EHV-1 challenge. These data show that the SMAA system is an effective way of presenting subviral components to the immune system and further emphasises the importance of including glycoprotein D as a component of a subunit EHV-1 vaccine.
Collapse
Affiliation(s)
- D G Alber
- Wolfson Institute for Biomedical Research, University College London, WC1E 6AU, London, UK
| | | | | |
Collapse
|
32
|
Thompson J, Smith J, Killough J, Scott M, Shagrin L, Stokes A, Horowitz H, Idzerda M. Calling all capital. NIC financing forum. Contemp Longterm Care 2000; 23:suppl 5-6, 8, 10-2. [PMID: 11556370] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 02/21/2023]
|
33
|
Haworth K, Shu KK, Stokes A, Morris R, Stoker A. The expression of receptor tyrosine phosphatases is responsive to sciatic nerve crush. Mol Cell Neurosci 1998; 12:93-104. [PMID: 9790732 DOI: 10.1006/mcne.1998.0707] [Citation(s) in RCA: 25] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/06/2023] Open
Abstract
Given the importance of phosphotyrosine signaling in growth cone dynamics, we have examined the embryonic and adult expression of receptor-like protein tyrosine phosphatases in sensory neurons and studied their responsiveness to nerve lesions in young adult animals. The phosphatases LAR, PTPsigma, and PTPalpha are expressed in most neurons of E14 and E18 rat embryo dorsal root ganglia, while BEM-1 is expressed in a more restricted subset of these neurons. These phosphatases continue to be expressed in young adult animals, suggesting that they have roles in mature as well as in developing dorsal root ganglia neurons. After an experimental sciatic nerve crush, the expression of the phosphatase genes was significantly and differentially altered in these neurons. PTPsigma mRNA was increased by 50% after 3 days, while LAR and PTPalpha expression dropped by 50 and 20%, respectively. BEM-1 mRNA levels were unaltered. These data show that mRNA levels of specific tyrosine phosphatase genes are highly responsive to nerve damage and may be reset to a new and potentially optimal pattern of expression more conducive for nerve regeneration. We propose that tyrosine phosphatases are not only involved in primary axonogenesis but can also now be implicated in the molecular control of adult nerve repair.
Collapse
Affiliation(s)
- K Haworth
- Department of Human Anatomy, University of Oxford, Oxford, OX1 3QX, UK
| | | | | | | | | |
Collapse
|
34
|
Bawden HN, Stokes A, Camfield CS, Camfield PR, Salisbury S. Peer relationship problems in children with Tourette's disorder or diabetes mellitus. J Child Psychol Psychiatry 1998; 39:663-8. [PMID: 9690930] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/08/2023]
Abstract
Peer relationships, social skills, self-esteem, parental psychopathology, and family functioning of children with Tourette's disorder and a chronic disease control group of children with diabetes mellitus were compared. Children with Tourette's disorder had poorer peer relationships than their classmates and were more likely to have extreme scores reflecting increased risk for peer relationship problems than children with diabetes mellitus, but did not report self-esteem problems or social skills deficits. Measures of peer relationships were not related to severity or duration of tics. Children with Tourette's disorder and Attention Deficit Hyperactivity Disorder were at increased risk for poor peer relationships. The psychosocial problems of children with Tourette's disorder do not appear to be the generic result of having a chronic disease.
Collapse
Affiliation(s)
- H N Bawden
- IWK Children's Hospital and Dalhousie University, Halifax, Canada
| | | | | | | | | |
Collapse
|
35
|
Stokes A. Short course to an education plan. Br Dent J 1998; 184:471. [PMID: 9642860 DOI: 10.1038/sj.bdj.4809666] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/07/2023]
|
36
|
Abstract
The smallest RNA segment (S10) of bluetongue virus (an orbivirus, family Reoviridae) encodes two closely related nonstructural proteins, the 229-amino-acid (aa) NS3 and the 216-aa NS3A. The proteins are found in glycosylated and nonglycosylated forms in infected cells (X. Wu, H. Iwata, S.-Y. Chen, R. W. Compans and P. Roy J. Virol. 66:7104-7112, 1992). The NS3/NS3A proteins have two hydrophobic domains (aa 118 to 141 and 162 to 182) and two potential asparagine-linked glycosylation sites (aa 63 and 150), one of which is located between the hydrophobic domains. To determine whether these features were used in the mature protein forms, we generated a series of mutants of the S10 gene and expressed them by using the vaccinia virus T7 polymerase transient-expression system. Our data indicate that both hydrophobic domains of NS3 span the cell membrane and that only the site at aa 150 is responsible for N-linked glycosylation of the NS3 proteins.
Collapse
Affiliation(s)
- O B Bansal
- Department of International Health, University of Alabama at Birmingham, 35294, USA
| | | | | | | | | |
Collapse
|
37
|
Skoog SJ, Stokes A, Turner KL. Oral desmopressin: a randomized double-blind placebo controlled study of effectiveness in children with primary nocturnal enuresis. J Urol 1997; 158:1035-40. [PMID: 9258137] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/05/2023]
Abstract
PURPOSE Desmopressin nasal spray has proved to be efficacious treatment of primary nocturnal enuresis. Oral desmopressin tablets would be a more easily used, convenient vehicle for our patients and their parents. We evaluated the effectiveness of oral desmopressin in decreasing the number of wet nights in patients with primary nocturnal enuresis. MATERIALS AND METHODS We performed a double-blind, placebo controlled, parallel group trial of oral desmopressin in 141 children 5 to 17 years old with documented primary nocturnal enuresis at 14 sites. Patients were screened for number of wet nights for 2 weeks before study entry. A minimum of 3 wet nights weekly for 2 consecutive weeks was required for study entry. Patients were randomized to receive 200, 400 or 600 mcg. desmopressin or placebo before bedtime. Fluids were restricted 2 hours before bedtime based on body weight. The primary efficacy variable was mean decrease in the number of wet nights recorded during the last 2-week treatment period. The percentage of responding patients and mean decrease from baseline in number of wet nights at 2, 4 and 6 weeks were also assessed. RESULTS The decrease in wet nights was 9, 20, 30 and 36% for placebo, and 200, 400, and 600 mcg. desmopressin orally per day, respectively. The 600 mcg. dose of oral desmopressin daily was statistically significantly different (p < 0.05) from placebo in decreasing wet nights. A complete or near complete response (0 to 2 wet nights) was noted in 3, 18, 33 and 24% of the patients who received placebo, and 200, 400 and 600 mcg. oral desmopressin daily, respectively. The 400 and 600 mcg. treatment groups were statistically significantly different (p < 0.05) from placebo. A less than 50% decrease in wet nights was noted in 83, 79, 64 and 61% of the patients who received placebo, and 200, 400 and 600 mcg. oral desmopressin daily, respectively. Oral desmopressin exhibited a dose response in the treatment of primary nocturnal enuresis. The linear trend for the decrease in wet nights was statistically significant (p < 0.05). CONCLUSIONS A dose of 600 mcg. oral desmopressin daily significantly decreased the mean number of wet nights when administered for 6 weeks. A higher dose may be necessary for an improved response.
Collapse
Affiliation(s)
- S J Skoog
- Division of Urology, Oregon Health Sciences University, Portland 97201-3098, USA
| | | | | |
Collapse
|
38
|
Stokes A, Cameron RS, Marshall RN, Killington RA. High level expression of equine herpesvirus 1 glycoproteins D and H and their role in protection against virus challenge in the C3H (H-2Kk) murine model. Virus Res 1997; 50:159-73. [PMID: 9282781 DOI: 10.1016/s0168-1702(97)00067-1] [Citation(s) in RCA: 21] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/05/2023]
Abstract
N and C-terminal truncated forms of equine herpesvirus 1 (EHV 1) glycoproteins gD and gH were expressed in baculovirus resulting in the production of secreted recombinant proteins. A carboxy-terminal histidine tag was included on each of the genes for protein isolation by nickel affinity chromatography. Recombinant gD was recognized by three gD specific monoclonal antibodies, 20C4, 5H6 and F3132. F3132 is a conformationally dependent monoclonal antibody with virus neutralizing activity. Expression of gH was confirmed by reacting the protein with the gH peptide specific antiserum R319. The truncated gD gene was also expressed as a beta-galactosidase fusion protein which was purified from E. coli by nickel affinity chromatography. C3H mice were inoculated with purified recombinant gD or gH or insect cells which had been infected with recombinant baculoviruses. Mice were subsequently challenged with EHV 1. Purified recombinant baculovirus gD provided the most protection and produced high levels of virus neutralizing antibodies. The gD fusion protein was less effective at protecting mice and insect cells infected with either of the recombinant baculoviruses or purified recombinant gH were poor at conferring protection. The results emphasize the importance of using purified proteins in vaccine formulations and of including EHV 1 gD as a component of a subunit vaccine.
Collapse
Affiliation(s)
- A Stokes
- Molecular Virology Group, Department of Microbiology, University of Leeds, UK.
| | | | | | | |
Collapse
|
39
|
Stokes A, Alber DG, Cameron RS, Marshall RN, Allen GP, Killington RA. The production of a truncated form of baculovirus expressed EHV-1 glycoprotein C and its role in protection of C3H (H-2Kk) mice against virus challenge. Virus Res 1996; 44:97-109. [PMID: 8879139 DOI: 10.1016/0168-1702(96)01339-1] [Citation(s) in RCA: 15] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/02/2023]
Abstract
A truncated form of the equine herpesvirus 1 (EHV-1) glycoprotein C (gC) gene was expressed in baculovirus. The gC signal sequence was substituted with the honeybee melittin signal sequence and the transmembrane region was replaced with a histidine tag. The recombinant virus produced high levels of gC in both the cells and supernatants of infected cells. The protein was present by 24 h and maximal secretion occurred at 96 h post-infection. The recombinant protein was antigenically authentic as shown by its reaction with each of a panel of individual monoclonal antibodies specific for the five distinct antigenic sites on EHV-1 gC. Recombinant gC was purified from the supernatant of infected cells by immuno-affinity chromatography and used to immunize C3H (H-2Kk haplotype) mice. This incurred a gC specific antibody response against both the recombinant protein and EHV-1 gC. 'Pepscan' analysis showed that the gC specific antibodies in serum from these mice reacted with the same epitopes on gC as those recognized by antibodies in convalescent equine sera (i.e. antibodies were specific to antigenic sites one and five). A third previously unrecognized antibody binding site at the carboxyl terminus was also detected (Antibody binding domain I). A T-cell proliferative response against EHV-1 was detected in splenocyte populations taken from vaccinated mice. Further, the recovery of virus from the lungs and turbinates following challenge of mice with EHV-1 was significantly reduced. These findings indicate that baculovirus expressed gC may contribute significantly to a subunit vaccine preparation aimed at protecting horses from EHV-1 infection.
Collapse
Affiliation(s)
- A Stokes
- Department of Microbiology, University of Leeds, UK
| | | | | | | | | | | |
Collapse
|
40
|
Bernstein DI, Creticos PS, Busse WW, Cohen R, Graft DF, Howland WC, Lumry WR, Pedinoff AJ, Ratner PH, Lim J, Stokes A, McNally C. Comparison of triamcinolone acetonide nasal inhaler with astemizole in the treatment of ragweed-induced allergic rhinitis. J Allergy Clin Immunol 1996; 97:749-55. [PMID: 8613630 DOI: 10.1016/s0091-6749(96)80151-5] [Citation(s) in RCA: 32] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/31/2023]
Abstract
BACKGROUND Few clinical trials have directly compared the efficacy of antihistamines with topical nasal corticosteroids. OBJECTIVE The study was performed to compare the efficacy and safety of triamcinolone acetonide nasal spray at a dose of 110 micro g in each nostril once daily with 10 mg of oral astemizole once daily for the treatment of seasonal allergic rhinitis. METHODS A multicenter, double-blind, parallel-group study was conducted in 239 patients who were randomized to receive either triamcinolone acetonide or astemizole. A 5-day, drug-free, lead-in period was followed by 4 weeks of double-blind treatment. One hundred four patients treated with triamcinolone acetonide and 105 patients treated with astemizole could be evaluated. RESULTS Overall, triamcinolone acetonide was more effective than astemizole in reducing total nasal symptoms, nasal stuffiness, nasal itching, and sneezing (p </= 0.01). Triamcinolone acetonide was superior to astemizole at weeks 1, 2, and 3 in reduction of the total nasal symptom score (p </= 0.0401) and in reduction of nasal stuffiness (p </= 0.05). Improvements in individual nasal symptoms (itching, postnasal drip, runny nose, and sneezing) were greater for triamcinolone acetonide at week 2 (p </= 0.01). Ocular symptoms improved from baseline in both groups. When pollen counts were correlated to mean nasal rhinitis scores, the triamcinolone acetonide group showed continued improvement from week 1 to week 2 in nasal symptoms when pollen counts were at their highest. During the same period, patients treated with astemizole failed to show improvement from week 1 to week 2. This study demonstrated that once daily administration of triamcinolone acetonide was more effective than astemizole for controlling nasal symptoms of seasonal allergic rhinitis, especially during the peak pollination period.
Collapse
Affiliation(s)
- D I Bernstein
- Division of Immunology, University of Cincinnati College of Medicine, OH 45267, USA
| | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
41
|
Stokes A, Alber DG, Greensill J, Amellal B, Carvalho R, Taylor LA, Doel TR, Killington RA, Halliburton IW, Meredith DM. The expression of the proteins of equine herpesvirus 1 which share homology with herpes simplex virus 1 glycoproteins H and L. Virus Res 1996; 40:91-107. [PMID: 8725124 DOI: 10.1016/0168-1702(95)01256-7] [Citation(s) in RCA: 23] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/01/2023]
Abstract
Several expression systems were used in studies aimed at characterizing the equine herpesvirus 1 (EHV-1) glycoprotein H and L homologues of HSV-1 (EHV-1 gH and gL) and the products were compared to the authentic proteins synthesized in virus infected cells. Using an in vitro transcription/translation system two gH species were detected (an unprocessed 89 kDa and a processed 116 kDa product). Three low molecular weight proteins were found in the case of gL (21.8 kDa, 22.9 kDa and 26.9 kDa) and these showed a slight reduction in mobility on the addition of microsomal membranes to the reactions. A gL fusion protein was produced in pGEX-2T, expression being confirmed by Western blotting using a gL-specific antiserum raised against a peptide incorporating the 13 carboxyl terminal amino acids of the protein. A gH specific peptide antiserum precipitated both gH and two smaller proteins from EHV-1 infected cells thought to be two forms of gL. Insect cells infected with gH or gL baculovirus recombinants were used to vaccinate C3H (H-2k) mice. Some protection against EHV-1 infection was conferred to the gH inoculated mice. The results will enable further studies on the importance of the gH and gL interaction in the pathogenesis of EHV-1 to be evaluated and their potential in contributing to a subunit vaccine to be assessed.
Collapse
Affiliation(s)
- A Stokes
- Department of Microbiology, University of Leeds, UK
| | | | | | | | | | | | | | | | | | | |
Collapse
|
42
|
Hierholzer J, Killington R, Stokes A. Preparation of antigens. Virology Methods Manual 1996. [PMCID: PMC7155557 DOI: 10.1016/b978-012465330-6/50004-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Download PDF] [Subscribe] [Scholar Register] [Indexed: 12/05/2022]
Abstract
This chapter describes the procedures of purification, concentration, and preservation of antigens. The most general concept to begin with is the most important—the microbiological purity of the starting viral culture. For every virus antigen, there should be a parallel normal antigen to serve as the negative control in the test. Normal antigens are prepared by shaminoculating cell cultures with negative culture material and following these cultures through the entire virus culture and antigen preparation steps in exact parallel fashion. Depending on the test and the day-to-day usage, many antigens are preserved by adding thimerosal to the final product to a final concentration of 1:10,000, or sodium azide to a final concentration of 0.1%. Special preparation of antigens is required for many diagnostic tests, monoclonal or polyclonal antibody production, and many enzyme immunoassays tests. Many viruses and antigens have their own peculiarities based on the specific properties of each virus group. Chromatography is considered to be the most effective means of producing purified preparations of virus proteins, this being achieved by gel filtration, ion exchange, or affinity chromatography.
Collapse
|
43
|
Alber DG, Greensill J, Killington RA, Stokes A. Role of T-cells, virus neutralising antibodies and complement-mediated antibody lysis in the immune response against equine herpesvirus type-1 (EHV-1) infection of C3H (H-2k) and BALB/c (H-2d) mice. Res Vet Sci 1995; 59:205-13. [PMID: 8588092 DOI: 10.1016/0034-5288(95)90003-9] [Citation(s) in RCA: 20] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/31/2023]
Abstract
The suitability of C3H (H-2k) and BALB/c (H-2d) mice for use as small animal models to study immunity to EHV-1 was assessed. An in vitro T cell response mediated by both CD4+ and CD8+ T cells was detected both during the acute phase of infection and after challenge with a second dose of EHV-1 at two months in lymphocyte populations taken from the spleens of both types of mouse. The responses were apparent until at least 61 days after the primary inoculation. After challenge, T cells from mice previously infected with EHV-1 responded by as early as day 3 after infection and higher levels of T cell proliferation were reached than in mice undergoing a primary infection. Immunological cross-reactivity with the closely related virus, EHV-4 was detected and some activity against herpes simplex virus type-1 (HSV-1) was observed during the acute phase of infection. T cell responses were detected in the draining cervical lymph nodes but not in the inguinal lymph nodes of the mice and these were the primary sites of T cell activation. Complement-dependent virus neutralising antibodies were present by day 8 after infection. These antibodies were also able to lyse EHV-1 infected target cells in vitro. Complement-independent virus neutralising antibodies were found before challenge only in C3H mice. The clinical signs and duration of virus shedding were reduced after challenge. The time course of the appearance of the different immune effector mechanisms is discussed in relation to the clearance of virus from the infected mice. The results suggest that C3H mice provide a better model in which to study potential vaccine candidates against EHV-1 infections of the horse than BALB/c mice.
Collapse
Affiliation(s)
- D G Alber
- Department of Microbiology, University of Leeds
| | | | | | | |
Collapse
|
44
|
Levine B, Lee W, Boyd G, Chrysant S, Dawson J, Gardner T, Hill G, Vergis J, Codispoti J, Stokes A. Conversion from 2.5 mg to 1.25 mg indapamide in patients with mild to moderate hypertension. J Fam Pract 1995; 41:75-80. [PMID: 7798068] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/22/2023]
Abstract
BACKGROUND Indapamide is an effective antihypertensive drug with diuretic and vasodilating activities. The common starting dose has been 2.5 mg to 5 mg. A lower dose formulation (1.25 mg) is now available. The safety and efficacy of switching patients from indapamide 2.5 mg to indapamide 1.25 mg was evaluated in this randomized, double-blind, multicenter clinical trial. METHODS Three hundred seventy-eight adult patients with mild to moderate essential hypertension were enrolled in a washout period, during which patients received single-blind placebo for 4 weeks. All 378 patients qualified for the study and received open-label treatment with indapamide 2.5 mg for 8 weeks. Of the 378 patients, 265 responded to indapamide 2.5 mg and were randomized to receive double-blind treatment with either indapamide 1.25 mg (n = 132) or 2.5 mg (n = 133) for 8 weeks. Overall, 245 of the 378 patients who were initially enrolled completed the study. The primary efficacy variable was the number of patients in each treatment group who maintained a supine diastolic blood pressure of < or = 90 mm Hg (treatment success) by the end of the double-blind period (week 16). RESULTS Treatment with indapamide 1.25 mg once daily was as efficacious as the 2.5-mg once-daily dose. No significant difference was observed for the percentage of patients who achieved treatment success between the patients switched from indapamide 2.5 to 1.25 mg (74%) and the control group maintained on indapamide 2.5 mg (70%). The incidence of drug-related adverse events during the double-blind period was similar between the two treatment groups. The mean change from pretreatment baseline to endpoint in serum potassium was -0.2 mEq/L (-0.2 mmol/L) in the indapamide 1.25 mg treatment group, compared with -0.4 mEq/L (-0.4 mmol/L) in the indapamide 2.5 mg treatment group. CONCLUSIONS Indapamide 1.25 mg given once daily for 8 weeks was as effective as 2.5 mg once daily in reducing systolic and diastolic blood pressure in patients with mild to moderate hypertension.
Collapse
Affiliation(s)
- B Levine
- VA Medical Center, Los Angeles, CA 90073, USA
| | | | | | | | | | | | | | | | | | | |
Collapse
|
45
|
Lim PF, Neo KH, Sitoh L, Yeo KL, Stokes A. Adaptation of finger-smoothed irreversible hydrocolloid to impression surfaces. INT J PROSTHODONT 1995; 8:117-21. [PMID: 7575961] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/26/2023]
Abstract
This study investigated a surface moistening technique in which the surface of an irreversible hydrocolloid impression material was smoothed using a moistened, gloved finger prior to impression making. To determine the effect of the procedure on the surface integrity of machined brass die, impressions with and without smoothed surfaces were made and examined. Similarly, multiple impressions were made for a single dentate subject, and stone casts were poured. These casts were assessed by three experienced clinicians. Results indicated that the moistened finger technique resulted in fewer surface bubbles and voids than did impressions made when the material was only loaded with a spatula and not smoothed.
Collapse
Affiliation(s)
- P F Lim
- Faculty of Dentistry, National University of Singapore
| | | | | | | | | |
Collapse
|
46
|
Weidler D, Jallad NS, Curry C, Ferdinand K, Jain AK, Schnaper HW, Toth PD, Codispoti J, Stokes A, McNally C. Efficacious response with lower dose indapamide therapy in the treatment of elderly patients with mild to moderate hypertension. J Clin Pharmacol 1995; 35:45-51. [PMID: 7751412 DOI: 10.1002/j.1552-4604.1995.tb04744.x] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/26/2023]
Abstract
A low dose (1.25 mg) of indapamide (Lozol, Rhône-Poulenc Rorer Pharmaceuticals, Collegeville, PA) was evaluated in 222 elderly patients (> or = 50 years) with mild to moderate essential hypertension in a multicenter, randomized, double-blind, parallel-group clinical trial. A 4-week single-blind placebo washout period was followed by an 8-week double-blind treatment period. Patients were randomized to receive indapamide 1.25 mg/day or to receive placebo. The primary efficacy variable was the mean change in sitting diastolic blood pressure from baseline to week 8. Eighty-one patients in the indapamide group (73%) and 87 patients in the placebo group (78%) completed the 8 weeks of double-blind therapy. Therapy with 1.25 mg of indapamide produced greater reductions compared with placebo in sitting diastolic blood pressure after 8 weeks of therapy, with statistical significance (P < or = 0.0015) seen after only 2 weeks of therapy and continuing throughout the 8 weeks. All secondary efficacy measures (sitting systolic blood pressure, standing systolic and diastolic blood pressures, and > or = 10 mm Hg decrease or final value of < or = 90 mm Hg in sitting diastolic blood pressure) also showed superior (P < or = 0.0014) improvement in the indapamide group compared with placebo after 8 weeks of double-blind treatment. During the 8-week double-blind treatment period, incidence rates for all adverse events and for drug-related adverse events were similar between the two treatment groups.(ABSTRACT TRUNCATED AT 250 WORDS)
Collapse
Affiliation(s)
- D Weidler
- University of Miami, Division of Clinical Pharmacology, FL 33136
| | | | | | | | | | | | | | | | | | | |
Collapse
|
47
|
Fiddes R, Heym H, Hilty W, Lewin AJ, Codispoti J, McNally C, Stokes A, Gilderman L. Blood pressure control with diltiazem XR, a novel extended-release formulation of diltiazem HCl, in mature and elderly hypertensive patients. Clin Ther 1994; 16:209-21. [PMID: 8062317] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/28/2023]
Abstract
The safety and efficacy of an extended-release form of diltiazem HCl (diltiazem XR) in patients 55 years or older with mild-to-moderate essential hypertension were examined in a multi-center, double-blind, randomized, placebo-controlled, parallel-group study involving 350 patients with supine diastolic blood pressure (DBP) between 95 mm Hg and 114 mm Hg. Patients were randomized to a once-daily dose of diltiazem XR (240 mg) or placebo; 261 patients received diltiazem XR and 89 received placebo. After 4 weeks, the dose was doubled (to 480 mg) in patients whose supine DBP was > 90 mm Hg, and treatment was continued for another 4 weeks. Diltiazem XR consistently reduced blood pressure (BP) in the study population. At end-point, the mean reduction in supine DBP was 8.65 mm Hg in the diltiazem XR group and 2.75 mm Hg in the placebo group (P < 0.0001). Subgroup analysis confirmed the efficacy of diltiazem XR in men, women, patients between the ages of 55 and 64 years, patients 65 years or older, and non-black patients. Other BP values (supine systolic, standing diastolic, and standing systolic) also were significantly reduced in patients treated with diltiazem XR. BP reduction (supine DBP < or = 90 mm Hg or by > or = 10 mm Hg) was achieved in 58% of patients receiving diltiazem XR compared with 27% of patients receiving placebo. Decreases in apical heart rate were minimal and similar in both groups. No significant differences were noted in adverse events in the diltiazem XR and placebo groups: 36.4% of patients in the diltiazem XR group and 37.1% in the placebo group had no adverse experiences, and 63.6% and 62.9%, respectively, had at least one adverse event. Physical examination findings and laboratory values were clinically unremarkable and comparable in the diltiazem XR and placebo groups. Diltiazem XR given once daily at doses of 240 mg and 480 mg was safe and effective in lowering blood pressure in mature and elderly patients with mild-to-moderate hypertension.
Collapse
Affiliation(s)
- R Fiddes
- Southern California Research Institute, Whittier
| | | | | | | | | | | | | | | |
Collapse
|
48
|
Abstract
We describe two patients with Tourette syndrome who also had pseudo-tics. The psychogenic movements resolved in both children when the stressful issues in their lives were addressed. It is important to differentiate psychogenic symptoms from tics and compulsions in children with Tourette syndrome in order to avoid unnecessary medication and allow appropriate therapy.
Collapse
Affiliation(s)
- J M Dooley
- Department of Pediatrics, Dalhousie University, Halifax, Nova Scotia, Canada
| | | | | |
Collapse
|
49
|
Stokes A, Tierney EL, Sarris CM, Murphy BR, Hall SL. The complete nucleotide sequence of two cold-adapted, temperature-sensitive attenuated mutant vaccine viruses (cp12 and cp45) derived from the JS strain of human parainfluenza virus type 3 (PIV3). Virus Res 1993; 30:43-52. [PMID: 8266719 DOI: 10.1016/0168-1702(93)90014-e] [Citation(s) in RCA: 22] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/29/2023]
Abstract
Two cold-passaged mutant vaccine viruses (cp12 and cp45) derived from the JS wild-type (wt) strain of human parainfluenza virus type 3 (PIV3) have been sequenced. These mutant viruses display the cold-adapted (ca), temperature-sensitive (ts), and attenuation (att) phenotypes. Sequence data indicate that both cp12 and cp45 sustained nucleotide substitutions during cold passage and subsequent cloning. Fifteen nucleotide changes were present in cp12 and 18 in cp45. Of these changes, some were present in the sequence of the prototype wt strain (Wash/47885/57) or were non-coding changes present in the open reading frames (ORFs). These were considered unlikely to be of significance in contributing to phenotypic differences between the mutants and the JS wt. There were nine remaining changes in cp12 and eight in cp45 that would most likely contribute to their phenotypes. For cp12, two were non-coding changes in regulatory regions, one in the 3' genome leader and one in the NP gene transcription start signal. The remaining seven changes resulted in amino acid substitutions in NP, F, HN, and L. For cp45, two mutations were in a non-coding regulatory region, the 3' genome leader. The remaining six changes resulted in amino acid substitutions in F, HN, and L. Only one amino acid substitution was conserved between cp12 and cp45 (a valine to alanine change at position 384 of the HN gene). These results should prove useful in the future in understanding the genetic basis of attenuation of the cold-passaged PIV3 candidate vaccine viruses.
Collapse
Affiliation(s)
- A Stokes
- Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892
| | | | | | | | | |
Collapse
|
50
|
Khachen W, Suthar J, Stokes A, Dollinger R, Dunbar W. Aerospace-specific design guidelines for electrical insulation. ACTA ACUST UNITED AC 1993. [DOI: 10.1109/14.237748] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
|